NDC 50458-178

Ortho-Novum 777

Norethindrone And Ethinyl Estradiol

Ortho-Novum 777 is a Kit in the Human Prescription Drug category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is .

Product ID50458-178_14421a91-80ef-495a-bcef-af09e5643e72
NDC50458-178
Product TypeHuman Prescription Drug
Proprietary NameOrtho-Novum 777
Generic NameNorethindrone And Ethinyl Estradiol
Dosage FormKit
Marketing Start Date1984-04-04
Marketing End Date2025-08-31
Marketing CategoryNDA / NDA
Application NumberNDA018985
Labeler NameJanssen Pharmaceuticals, Inc.
Active Ingredient Strength0
NDC Exclude FlagN

Packaging

NDC 50458-178-20

48 DIALPACK in 1 CARTON (50458-178-20) > 1 KIT in 1 DIALPACK (50458-178-00)
Marketing Start Date1984-04-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50458-178-28 [50458017828]

Ortho-Novum 777 KIT
Marketing CategoryNDA
Application NumberNDA018985
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-03-02
Marketing End Date2025-08-31

NDC 50458-178-15 [50458017815]

Ortho-Novum 777 KIT
Marketing CategoryNDA
Application NumberNDA018985
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1984-04-04
Marketing End Date2020-08-31

NDC 50458-178-00 [50458017800]

Ortho-Novum 777 KIT
Marketing CategoryNDA
Application NumberNDA018985
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1984-04-04
Marketing End Date2025-08-31

NDC 50458-178-06 [50458017806]

Ortho-Novum 777 KIT
Marketing CategoryNDA
Application NumberNDA018985
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-02-01
Marketing End Date2020-03-31

NDC 50458-178-20 [50458017820]

Ortho-Novum 777 KIT
Marketing CategoryNDA
Application NumberNDA018985
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1984-04-04
Marketing End Date2018-03-31

NDC 50458-178-12 [50458017812]

Ortho-Novum 777 KIT
Marketing CategoryNDA
Application NumberNDA018985
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-10-10
Marketing End Date2019-07-31

Drug Details

OpenFDA Data

SPL SET ID:2524b253-069e-4028-819c-361b888df110
Manufacturer
RxNorm Concept Unique ID - RxCUI
  • 748797
  • 749852
  • 310463
  • 749853
  • 749859
  • 749858
  • 392662
  • 312033
  • Medicade Reported Pricing

    50458017820 ORTHO-NOVUM 7-7-7-28 TABLET

    Pricing Unit: EA | Drug Type:

    50458017815 ORTHO-NOVUM 7-7-7-28 TABLET

    Pricing Unit: EA | Drug Type:

    50458017800 ORTHO-NOVUM 7-7-7-28 TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Ortho-Novum 777" or generic name "Norethindrone And Ethinyl Estradiol"

    NDCBrand NameGeneric Name
    50458-178Ortho-Novum 777Ortho-Novum 777
    50090-1477ALYACEN 1/35norethindrone and ethinyl estradiol
    50090-1478ALYACEN 7/7/7norethindrone and ethinyl estradiol
    0555-9066Aranellenorethindrone and ethinyl estradiol
    0555-9034BalzivaNorethindrone and Ethinyl Estradiol
    0603-7521Cyclafem 1/35norethindrone and ethinyl estradiol
    0603-7525Cyclafem 7/7/7norethindrone and ethinyl estradiol
    16714-348Dasetta 1/35Norethindrone and Ethinyl Estradiol
    16714-346Dasetta 7/7/7norethindrone and ethinyl estradiol
    21695-857NeconNorethindrone and Ethinyl Estradiol
    0093-3303Necon 1/35Norethindrone and Ethinyl Estradiol
    0555-9008NortrelNorethindrone and Ethinyl Estradiol
    0555-9009NortrelNorethindrone and Ethinyl Estradiol
    0555-9010NortrelNorethindrone and Ethinyl Estradiol
    0555-9012Nortrel 7/7/7Norethindrone and Ethinyl Estradiol
    50090-0159Ortho-Novumnorethindrone and ethinyl estradiol
    16714-370Weranorethindrone and ethinyl estradiol
    50090-1431WeraNorethindrone and Ethinyl Estradiol

    Trademark Results [Ortho-Novum]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ORTHO-NOVUM
    ORTHO-NOVUM
    72111210 0725248 Live/Registered
    ORTHO PHARMACEUTICAL CORPORATION
    1961-01-03

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.